![[ACT EU Workplan for 2026-2027 – Version 4, May 2026]](https://cddf.org/wp-content/uploads/2026/05/Capture-1080x675.jpg)
![[News from ACT EU] – Clinical Trials Information System (CTIS): training and support](https://cddf.org/wp-content/uploads/2026/04/Copy-of-PUBLICATION-Annual-Repport-2024-Is-available-4-1080x675.jpg)
[News from ACT EU] – Clinical Trials Information System (CTIS): training and support
Check out the publication of a new EMA document of frequently asked questions (FAQ) for sponsors on the Clinical Trials Information System (CTIS):...![[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice](https://cddf.org/wp-content/uploads/2026/03/EMA-News-1080x675.jpg)
[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice
🔔📢The European Medicines Agency has published for public consultation: a Concept paper on the guideline revision on good pharmacogenomic practice. Since its initial publication in 2018, the guideline on good pharmacogenomic practice has played a crucial role in...
ACT EU: MSP AG – Call for Expressions of Interest
📢 🔔Take a look at the below ‘Call for Expressions of Interest’ from the Multi-stakeholder Platform Advisory Group (MSP AG) under ACT EU: ▶️ Message from ACT EU: MSP AG “Call for Expression of Interest – Focus Group on the review of the Guideline for...
ACT EU:Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making
ACT EU is pleased to announce a hybrid workshop on 3 November 2025: “Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making” Registration: Please register via the ACT EU website here: Workshop Registration The Methodology...